Pacritinib and its Impurities

Pacritinib, marketed under the brand name Vonjo. it is a targeted therapy used to treat myelofibrosis, a rare bone marrow disorder. Reference standards of Pacritinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.